GlaxoSmithKline plc (GSK) (LSE/NYSE:GSK) is gearing up for the demerger of its consumer healthcare business, which it anticipates will be complicated in July. The company announced that it had enlisted six new directors to the designate board of the spinoff, which will be known as Haleon. In addition to Sir Dave Lewis, whom the GSK named…
GSK names consumer health spinoff ‘Haleon’
GlaxoSmithKline plc (GSK) is moving forward with a planned demerger of its consumer healthcare segment, which it will call Haleon. The company notes that the name is a portmanteau of the old English word ‘hale’ and the name ‘Leon.’ The former means ‘healthy’ while the latter is a reference to strength. In the past eight…